| Year |
Citation |
Score |
| 2023 |
Lu Q, Yan W, Zhu A, Tubin S, Mourad WF, Yang J. Combining spatially fractionated radiation therapy (SFRT) and immunotherapy opens new rays of hope for enhancing therapeutic ratio. Clinical and Translational Radiation Oncology. 44: 100691. PMID 38033759 DOI: 10.1016/j.ctro.2023.100691 |
0.337 |
|
| 2020 |
Jiang L, Li X, Zhang J, Li W, Dong F, Chen C, Lin Q, Zhang C, Zheng F, Yan W, Zheng Y, Wu X, Xu B. Combined High-Dose LATTICE Radiation Therapy and Immune Checkpoint Blockade for Advanced Bulky Tumors: The Concept and a Case Report. Frontiers in Oncology. 10: 548132. PMID 33643893 DOI: 10.3389/fonc.2020.548132 |
0.301 |
|
| 2020 |
Yan W, Khan MK, Wu X, Simone CB, Fan J, Gressen E, Zhang X, Limoli CL, Bahig H, Tubin S, Mourad WF. Spatially fractionated radiation therapy: History, present and the future. Clinical and Translational Radiation Oncology. 20: 30-38. PMID 31768424 DOI: 10.1016/J.Ctro.2019.10.004 |
0.339 |
|
| 2019 |
Tubin S, Khan MK, Salerno G, Mourad WF, Yan W, Jeremic B. Mono-institutional phase 2 study of innovative Stereotactic Body RadioTherapy targeting PArtial Tumor HYpoxic (SBRT-PATHY) clonogenic cells in unresectable bulky non-small cell lung cancer: profound non-targeted effects by sparing peri-tumoral immune microenvironment. Radiation Oncology (London, England). 14: 212. PMID 31771654 DOI: 10.1186/S13014-019-1410-1 |
0.349 |
|
| 2018 |
Buchwald ZS, Wynne J, Nasti TH, Zhu S, Mourad WF, Yan W, Gupta S, Khleif SN, Khan MK. Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing, Dose and Fractionation. Frontiers in Oncology. 8: 612. PMID 30619752 DOI: 10.3389/Fonc.2018.00612 |
0.368 |
|
| 2018 |
Chen J, Wu X, Christos P, Yan W, Ravi A. Adjuvant Radiation Therapy for T3N0 Breast Cancer Patients Older Than 75 Years After Mastectomy: A SEER Analysis. Clinical Breast Cancer. PMID 29914691 DOI: 10.1016/J.Clbc.2018.05.002 |
0.464 |
|
| 2017 |
Mourad WF, Packianathan S, Yan W, Pishgou M, Ma JK, Shaaban SG, Marchan EM, He R, Mobit PN, Yang CC, Vijayakumar S. Reliable Radiation Technique to Minimize Ovarian Dose During Radiation Prophylaxis of Heterotopic Ossification. Anticancer Research. 37: 6929-6935. PMID 29187475 DOI: 10.21873/Anticanres.12157 |
0.372 |
|
| 2017 |
Mourad WF, Ma JK, Packianathan S, Yan W, Shaaban SG, Marchan EM, Abdallah LE, He R, Mobit PN, Yang CC, Vijayakumar S. Testicular Dose During Prophylaxis of Heterotopic Ossification with Radiation Therapy. In Vivo (Athens, Greece). 31: 461-466. PMID 28438880 DOI: 10.21873/Invivo.11084 |
0.353 |
|
| 2016 |
Nagar H, Yan W, Parashar B, Nori D, Chao KS, Christos P, Gupta D, Holcomb K, Caputo T, Wernicke AG. Adjuvant Pelvic Radiation Therapy±Vaginal Brachytherapy in Patients With High-risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-grade Endometrioid Carcinoma. American Journal of Clinical Oncology. PMID 27028349 DOI: 10.1097/Coc.0000000000000065 |
0.437 |
|
| 2016 |
Mann JM, Osian AD, Brandmaier A, Yan W, Sung KJ, Siegel B, Fink S, Kaplan B, Fulman M, Wu G, Christos P, Nori D, Ravi A. Excellent Long-term Breast Preservation Rate After Accelerated Partial Breast Irradiation Using a Balloon Device. Clinical Breast Cancer. PMID 26948247 DOI: 10.1016/J.Clbc.2016.02.010 |
0.435 |
|
| 2015 |
Ye JC, Yan W, Christos PJ, Nori D, Ravi A. Equivalent Survival With Mastectomy or Breast-conserving Surgery Plus Radiation in Young Women Aged < 40 Years With Early-Stage Breast Cancer: A National Registry-based Stage-by-Stage Comparison. Clinical Breast Cancer. PMID 25957740 DOI: 10.1016/J.Clbc.2015.03.012 |
0.441 |
|
| 2015 |
Ye JC, Yan W, Christos P, Nori D, Chao KS, Ravi A. Second cancer, breast cancer, and cardiac mortality in stage T1aN0 breast cancer patients with or without external beam radiation therapy: a national registry study. Clinical Breast Cancer. 15: 54-9. PMID 25223278 DOI: 10.1016/J.Clbc.2014.07.003 |
0.444 |
|
| 2015 |
Ye JC, Yan W, Christos P, Nori D, Chao KSC, Ravi A. Second cancer, breast cancer, and cardiac mortality in stage T1aN0 breast cancer patients with or without external beam radiation therapy: A national registry study Clinical Breast Cancer. 15: 54-59. DOI: 10.1016/j.clbc.2014.07.003 |
0.341 |
|
| 2014 |
Nagar H, Yan W, Christos P, Chao KS, Nori D, Ravi A. Older Patients With Early-stage Breast Cancer: Adjuvant Radiation Therapy and Predictive Factors for Cancer-related Death. American Journal of Clinical Oncology. PMID 25333731 DOI: 10.1097/Coc.0000000000000144 |
0.408 |
|
| 2014 |
Ye J, Yan W, Christos P, Nori D, Chao K, Ravi A. Triple-Negative Receptor Status and Other Predictors of Lymph Node Positivity in Small (T1) Breast Cancers: A National Registry Study International Journal of Radiation Oncology*Biology*Physics. 90: S248. DOI: 10.1016/J.Ijrobp.2014.05.873 |
0.361 |
|
| 2014 |
Nagar H, Yan W, Parashar B, Nori D, Chao K, Christos P, Gupta D, Holcomb K, Caputo T, Wernicke A. Treatment With Adjuvant Pelvic Radiation Therapy ± Vaginal Brachytherapy in Patients With High-Risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-Grade Endometrioid Carcinoma International Journal of Radiation Oncology Biology Physics. 90. DOI: 10.1016/J.Ijrobp.2014.05.1518 |
0.393 |
|
| 2013 |
Yan W, Christos P, Nori D, Chao KSC, Ravi A. Is there a cause-specific survival benefit of postmastectomy radiation therapy in women younger than age 50 with T3N0 invasive breast cancer? A SEER database analysis: Outcomes by receptor Status/race/age : Using the NCI surveillance, epidemiology, and end results (SEER) database American Journal of Clinical Oncology: Cancer Clinical Trials. 36: 552-557. PMID 22868241 DOI: 10.1097/Coc.0B013E31825D529B |
0.458 |
|
| 2013 |
Ye J, Yan W, Christos P, Nori D, Chao K, Ravi A. Breast Cancer (BC), Second Cancer, and Cardiac Mortality in Stage T1aN0 BC Patients With or Without External Beam Radiation Therapy (XRT): NCI SEER Study International Journal of Radiation Oncology*Biology*Physics. 87: S46. DOI: 10.1016/J.Ijrobp.2013.06.122 |
0.442 |
|
| 2012 |
Christos PJ, Nori D, Chao C, Yan W. Age, hormone receptor status, ethnicity, and adjuvant radiation therapy as predictive factors for cancer-related death in patients age 70 and older with early-stage pT1a,b N0 breast cancer: An NCI-SEER database analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 155. PMID 28146763 DOI: 10.1200/Jco.2012.30.27_Suppl.155 |
0.435 |
|
| 2012 |
Wernicke AG, Shamis M, Yan W, Trichter S, Sabbas AM, Goltser Y, Christos PJ, Brennan JS, Parashar B, Nori D. Role of isotope selection in long-term outcomes in patients with intermediate-risk prostate cancer treated with a combination of external beam radiotherapy and low-dose-rate interstitial brachytherapy. Urology. 79: 1098-104. PMID 22546388 DOI: 10.1016/J.Urology.2012.01.043 |
0.366 |
|
| 2012 |
Yan W, Christos P, Nori D, Chao CK, Wernicke G. SEER Analysis of Adjuvant Pelvic Radiation Therapy or Vaginal Brachytherapy in Treating Patients With High-Risk Stage I or Stage II Papillary Serous, Clear Cell, and High Grade Endometrioid Carcinoma International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.1190 |
0.412 |
|
| 2012 |
Yan W, Christos P, Nori D, Chao CK, Ravi A. Age, Hormonal Receptor Status, Ethnicity, and Adjuvant Radiation Therapy as Predictive Factors for Cancer-related Death in Elderly Patients Aged 70 Years and Older With Early Stage pT1a,b N0 Breast Cancer: A NCI-SEER Database Analysis International Journal of Radiation Oncology Biology Physics. 84. DOI: 10.1016/J.Ijrobp.2012.07.095 |
0.44 |
|
| 2011 |
Patel PS, Yan W, Trichter S, Sabbas A, Rosenblatt R, Drotman MB, Swistel A, Chao KS, Nori D, Hayes MK. Seroma is an expected consequence and not a complication of MammoSite brachytherapy. The Breast Journal. 17: 498-502. PMID 21827558 DOI: 10.1111/J.1524-4741.2011.01127.X |
0.392 |
|
| 2011 |
Yan W, Christos P, Chao K, Nori D, Ravi A. Post-mastectomy Radiation Therapy in Younger Women Aged Less Than 50 with T3N0 Invasive Breast Cancer: Outcomes by Receptor Status/Race/Age International Journal of Radiation Oncology Biology Physics. 81. DOI: 10.1016/J.Ijrobp.2011.06.070 |
0.401 |
|
| 2010 |
Hirsh AZ, Yan W, Wei L, Wernicke AG, Parashar B. Unresectable retiform hemangioendothelioma treated with external beam radiation therapy and chemotherapy: a case report and review of the literature. Sarcoma. 2010. PMID 20936126 DOI: 10.1155/2010/756246 |
0.396 |
|
| 2009 |
McGuirk J, Hao G, Hou W, Abhyankar S, Williams C, Yan W, Yuan J, Guan X, Belt R, Dejarnette S, Wieman J, Yan Y. Serum proteomic profiling and haptoglobin polymorphisms in patients with GVHD after allogeneic hematopoietic cell transplantation. Journal of Hematology & Oncology. 2: 17. PMID 19379511 DOI: 10.1186/1756-8722-2-17 |
0.48 |
|
| 2008 |
Hirsh AZ, Yan W, Castano E, Hirsh AL, Brennan JS, Christos PJ, Parashar B, Nori D, Wernicke AG. Acute/Late Toxicities and Predictors of Erectile Function in Patients with Intermediate Risk Prostate Cancer Treated with Combined Modality External Beam Radiotherapy and Interstitial Brachytherapy International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.1459 |
0.348 |
|
| 2008 |
Wernicke AG, Hirsh AZ, Yan W, Castano E, Hirsh A, Brennan JS, Christos PJ, Parashar B, Nori D. The Role of Isotope Selection and use of Hormonal Therapy in Long Term Outcomes in Patients with Intermediate Risk Prostate Cancer Treated with Combination of External Beam Radiotherapy and Low-dose Rate Interstitial Brachytherapy International Journal of Radiation Oncology Biology Physics. 72. DOI: 10.1016/J.Ijrobp.2008.06.1136 |
0.38 |
|
| Show low-probability matches. |